Allergic Conjunctivitis: Review of Current Types, Treatments, and Trends [PDF]
Allergic conjunctivitis is an allergen-induced immune response secondary to the binding of immunoglobulin-E (IgE) to sensitized mast cells. Approximately 40% of North Americans and 20% of the world’s population are impacted by some form of allergy and it
Fiza Tariq
europepmc +2 more sources
Cytokines in Allergic Conjunctivitis: Unraveling Their Pathophysiological Roles. [PDF]
Allergic conjunctivitis is one of the common immune hypersensitivity disorders that affect the ocular system. The clinical manifestations of this condition exhibit variability contingent upon environmental factors, seasonal dynamics, and genetic ...
Chigbu DI, Karbach NJ, Abu SL, Hehar NK.
europepmc +2 more sources
Safety and efficacy of a novel 0.5% epinastine topical eyelid cream in allergic conjunctivitis: a phase 3 trial. [PDF]
The high prevalence of allergic conjunctivitis in Japan necessitates novel, easy-to-use treatment options for prophylactic use. We evaluated the safety and efficacy of a newly-developed 0.5% epinastine topical eyelid cream to prevent the development of ...
Fujishima H, Shoji J.
europepmc +2 more sources
Background To establish a novel delivery system of pemirolast potassium-loaded gellan gum in situ gel in allergic conjunctivitis therapy. Methods The prepared in situ gels were studied in the following aspects: in vitro gelation, in vitro release ...
Ting Shen, Zijian Yang
semanticscholar +3 more sources
Correlation between forkhead box P3 (rs3761548) gene polymorphism and serum interleukin13 as biomarkers of severity in Egyptian allergic conjunctivitis: a retrospective study [PDF]
IntroductionThe genetic variants that alter human Forkhead Box P3 (FOXP3) function may have a part in the establishment of allergic conjunctivitis. Our study aimed to evaluate the FOXP3 polymorphism, serum interleukin13 (IL13) and total immunoglobulin E (
Wesam A. Boghdady +6 more
doaj +2 more sources
Purpose: With increasing environmental pollution, the incidence of allergic conjunctivitis is increasing. Newer anti-allergic medications with combined anti-histaminic and mast cell stabilization action can help reducing the use of topical steroids for ...
Lakshey Dudeja +4 more
doaj +2 more sources
Immunopathology of Allergic Conjunctivitis
Allergic conjunctivitis is predominantly an immunoglobulin E-mediated hypersensitivity reaction to environmental allergens. Allergic diseases affect >30% of the world’s population, of which 40% report associated ocular manifestations. Cellular and soluble mediators play a major role in the pathophysiology of allergic conjunctivitis.
DeGaulle I. Chigbu, Bhawanjot K. Minhas
openaire +3 more sources
New medical big data for P4 medicine on allergic conjunctivitis
Allergic conjunctivitis affects approximately 15–20% of the global population and can permanently deteriorate one's quality of life (QoL) and work productivity, leading to societal work force costs.
Takenori Inomata +11 more
doaj +2 more sources
Evaluation of Antiallergic Conjunctivitis Effects of Extract of Nelumbo nucifera Rhizome and Its Isolated Constituents Against Chemical-Induced Allergic Conjunctivitis in Experimental Rats [PDF]
Allergic conjunctivitis, an inflammation of the conjunctiva, is commonly treated with conventional drugs such as mast cell stabilizers, corticosteroids, antihistamines, NSAIDs, and others; these drugs associated lots of side effects including dryness ...
Phool Chandra +7 more
doaj +2 more sources
Citation: 'allergic conjunctivitis' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.13037 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms ...
Baab S, Le PH, Gurnani B, Kinzer EE.
europepmc +4 more sources

